Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Citarinostat |
| Trade Name | |
| Synonyms | ACY-241|CC-96241 |
| Drug Descriptions |
Citarinostat (ACY-241) selectively inhibits HDAC6, which potentially results in decreased tumor cell viability and reduced tumor growth, particularly in combination with other agents (PMID: 27926524, PMID: 28264055, PMID: 32394008). |
| DrugClasses | HDAC Inhibitor 45 |
| CAS Registry Number | 1316215-12-9 |
| NCIT ID | C121641 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Citarinostat | Citarinostat | 0 | 2 |
| Citarinostat + Ipilimumab + Nivolumab | Citarinostat Ipilimumab Nivolumab | 0 | 2 |
| Citarinostat + Paclitaxel | Citarinostat Paclitaxel | 0 | 0 |
| Citarinostat + Pomalidomide | Citarinostat Pomalidomide | 0 | 0 |